Yao, Lina http://orcid.org/0000-0003-1018-5646
D’Agostino, Gabriel D.
Park, Jinseok
Hang, Saiyu
Adhikari, Arijit A.
Zhang, Yancong http://orcid.org/0000-0002-2768-2975
Li, Wei
Avila-Pacheco, Julian http://orcid.org/0000-0001-9388-3946
Bae, Sena
Clish, Clary B. http://orcid.org/0000-0001-8259-9245
Franzosa, Eric A. http://orcid.org/0000-0002-8798-7068
Huttenhower, Curtis http://orcid.org/0000-0002-1110-0096
Huh, Jun R. http://orcid.org/0000-0002-1540-6244
Devlin, A. Sloan http://orcid.org/0000-0001-5598-3751
Funding for this research was provided by:
Foundation for the National Institutes of Health (DK110559)
U.S. Department of Health & Human Services | National Institutes of Health (GM128618, DK110559)
Article History
Received: 7 September 2021
Accepted: 20 June 2022
First Online: 18 August 2022
Competing interests
: A.S.D. is a consultant for Takeda Pharmaceuticals and Axial Therapeutics. J.R.H. is a consultant for CJ Research Center, LLC. C.H. is on the scientific advisory boards of Seres Therapeutics, Empress Therapeutics, and ZOE Nutrition. The other authors declare no competing interests.